XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statement of Shareholders' (Deficit) Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Public Offering
Public Offering
Common Shares
Public Offering
Additional Paid-in Capital
Cowen and Company, LLC
Private Placement
Cowen and Company, LLC
Private Placement
Common Shares
Cowen and Company, LLC
Private Placement
Additional Paid-in Capital
Beginning balance (in shares) at Mar. 31, 2019   72,057,490                  
Beginning balance at Mar. 31, 2019 $ 4,334 $ 1 $ 505,851 $ 507 $ (502,025)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of shares (in shares)             17,424,243     106,494  
Issuance of shares           $ 134,538 $ 1 $ 134,537 $ 2,546   $ 2,546
Share-based compensation expense 6,410   6,410                
Capital contribution from former controlling shareholder — share-based compensation 42   42                
Capital contribution from former controlling shareholder 106   106                
Foreign currency translation adjustment (819)     (819)              
Issuance of shares upon exercise of stock options and vesting of restricted stock units (in shares)   34,399                  
Issuance of shares upon exercise of stock options and vesting of restricted stock units 314   314                
Net loss (67,904)       (67,904)            
Ending balance (in shares) at Jun. 30, 2019   89,622,626                  
Ending balance at Jun. 30, 2019 $ 79,567 $ 2 649,806 (312) (569,929)            
Beginning balance (in shares) at Mar. 31, 2020 89,833,998 89,833,998                  
Beginning balance at Mar. 31, 2020 $ (108,277) $ 2 684,381 (1,646) (791,014)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation expense 7,812   7,812                
Foreign currency translation adjustment (3,475)     (3,475)              
Issuance of shares upon exercise of stock options and vesting of restricted stock units (in shares)   303,014                  
Issuance of shares upon exercise of stock options and vesting of restricted stock units 2,190   2,190                
Net loss $ (32,860)       (32,860)            
Ending balance (in shares) at Jun. 30, 2020 90,137,012 90,137,012                  
Ending balance at Jun. 30, 2020 $ (134,610) $ 2 $ 694,383 $ (5,121) $ (823,874)